NASDAQ:OPK OPKO Health - OPK Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.23 -0.03 (-2.38%) (As of 01/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.22▼$1.2750-Day Range$1.05▼$1.6152-Week Range$1.03▼$3.78Volume2.00 million shsAverage Volume2.59 million shsMarket Capitalization$950.40 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability OPKO Health MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside184.6% Upside$3.50 Price TargetShort InterestBearish9.06% of Float Sold ShortDividend StrengthN/ASustainability-1.65Upright™ Environmental ScoreNews Sentiment0.64Based on 4 Articles This WeekInsider TradingAcquiring Shares$767,000 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.43) to ($0.33) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.49 out of 5 starsMedical Sector166th out of 1,049 stocksPharmaceutical Preparations Industry77th out of 514 stocks 3.5 Analyst's Opinion Consensus RatingOPKO Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.50, OPKO Health has a forecasted upside of 184.6% from its current price of $1.23.Amount of Analyst CoverageOPKO Health has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.06% of the float of OPKO Health has been sold short.Short Interest Ratio / Days to CoverOPKO Health has a short interest ratio ("days to cover") of 15.1, which indicates bearish sentiment.Change versus previous monthShort interest in OPKO Health has recently decreased by 2.50%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldOPKO Health does not currently pay a dividend.Dividend GrowthOPKO Health does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOPKO Health has received a 66.30% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Calcifediol", "Diagnostic test kits", and "Clinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for OPKO Health is -1.65. Previous Next 3.1 News and Social Media Coverage News SentimentOPKO Health has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for OPKO Health this week, compared to 2 articles on an average week.Search Interest26 people have searched for OPK on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.MarketBeat Follows6 people have added OPKO Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OPKO Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $767,000.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders40.97% of the stock of OPKO Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.49% of the stock of OPKO Health is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for OPKO Health are expected to grow in the coming year, from ($0.43) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OPKO Health is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OPKO Health is -2.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOPKO Health has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OPKO Health (NASDAQ:OPK) StockOPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.Read More Receive OPK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPK Stock News HeadlinesJanuary 25, 2023 | americanbankingnews.comOPKO Health (NASDAQ:OPK) Shares Gap Down to $1.49January 24, 2023 | marketwatch.comStudy Latest Dravet Syndrome Thereapeutics Market Report 2023 Is Booming Globally by 2028 with Leading CAGRJanuary 30, 2023 | Investing Trends (Ad)Profit From the Commercial Solar Boom?Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. January 24, 2023 | benzinga.comOPKO Health Stock (NASDAQ:OPK), Quotes and News SummaryJanuary 17, 2023 | msn.comIsrael stocks higher at close of trade; TA 35 up 0.19%January 14, 2023 | finance.yahoo.comIs There An Opportunity With OPKO Health, Inc.'s (NASDAQ:OPK) 44% Undervaluation?January 13, 2023 | marketwatch.comWith 5% CAGR, Clinical Reference Laboratory Services Market 2023 Is Flourishing Around the World by 2028 | 111 Pages ReportJanuary 12, 2023 | marketwatch.comClinical Laboratory Tests Market: Exponential Growth Expected with Complete SWOT Analysis by Forecast from 2023 to 2028January 30, 2023 | Investing Trends (Ad)"We need batteries. Literally everywhere."Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense." January 11, 2023 | marketwatch.comClinical Laboratory Tests Market Statistics 2023 : Industry Demand, Prominent Players Strategies, Size, SWOT Analysis and Forecast 2028January 10, 2023 | marketwatch.comClinical Laboratory Test Market 2023 Expected to Witness the Highest Revenue Growth Over Forecast to 2028January 3, 2023 | finance.yahoo.comOPKO Health to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 29, 2022 | msn.comIsrael stocks higher at close of trade; TA 35 up 0.53%December 29, 2022 | seekingalpha.comNo Cure For OPKO Health, Inc.December 28, 2022 | finance.yahoo.com3 Reasons to Retain OPKO Health (OPK) Stock in Your PortfolioDecember 24, 2022 | thestreet.comOPKO Health (OPK) Stock Continues to Slip After Bio-Reference Labs AcquisitionDecember 21, 2022 | msn.comIsrael stocks higher at close of trade; TA 35 up 0.94%November 23, 2022 | marketwatch.comSmart Inhalers Market Size 2022 Global Analysis Report by Segmentation, Regions, Company Sales, Revenue, Production Capacity and Forecast to 2026November 16, 2022 | finance.yahoo.comPhillip Frost Is The Chairman & CEO of OPKO Health, Inc. (NASDAQ:OPK) And Just Spent US$319k On SharesNovember 11, 2022 | benzinga.comOPKO Health, electroCore And This Penny Stock Insiders Are Aggressively BuyingNovember 9, 2022 | finance.yahoo.comOPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues TopNovember 9, 2022 | seekingalpha.comOPKO Health, Inc. (OPK) Q3 2022 Earnings Call TranscriptNovember 8, 2022 | finance.yahoo.comOPKO Health Reports Third Quarter 2022 Business Highlights and Financial ResultsNovember 1, 2022 | finance.yahoo.comOPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022October 30, 2022 | finance.yahoo.comOPKO Health, Inc. (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven't stopped buyingOctober 21, 2022 | msn.comOPKO Health And 2 Other Penny Stocks Are Aggressively BuyingOctober 20, 2022 | marketwatch.comDigital Inhalers Market 2022 Company Challenges, Latest Advancements, Growth Prediction, and Forecast by 2028See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OPK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter. Email Address OPK Company Calendar Last Earnings11/08/2022Today1/30/2023Next Earnings (Estimated)2/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:OPK CUSIP68375N10 CIK944809 Webwww.opko.com Phone(305) 575-4100Fax305-575-6015Employees5,767Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.50 High Stock Price Forecast$4.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+184.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-30,140,000.00 Net Margins-25.98% Pretax Margin-29.11% Return on Equity-14.79% Return on Assets-10.57% Debt Debt-to-Equity Ratio0.09 Current Ratio1.55 Quick Ratio1.28 Sales & Book Value Annual Sales$1.22 billion Price / Sales0.78 Cash Flow$0.07 per share Price / Cash Flow17.38 Book Value$2.47 per share Price / Book0.50Miscellaneous Outstanding Shares772,686,000Free Float456,117,000Market Cap$950.40 million OptionableOptionable Beta1.65 Key ExecutivesPhillip FrostChairman & Chief Executive OfficerElias A. ZerhouniVice Chairman & PresidentAdam E. LogalCFO, Treasurer, Chief Accounting Officer & SVPJane H. HsaioVice Chairman & Chief Technical OfficerSteven D. RubinDirector & Executive Vice President-AdministrationKey CompetitorsImmunoGenNASDAQ:IMGNInnovivaNASDAQ:INVAIntercept PharmaceuticalsNASDAQ:ICPTLigand PharmaceuticalsNASDAQ:LGNDGeronNASDAQ:GERNView All CompetitorsInsiders & InstitutionsShufro Rose & Co. LLCBought 14,000 shares on 1/25/2023Ownership: 0.005%Norris Perne & French LLP MISold 9,000 shares on 1/24/2023Ownership: 0.007%Transcend Capital Advisors LLCBought 20,000 shares on 1/20/2023Ownership: 0.007%Sequoia Financial Advisors LLCBought 103,971 shares on 1/18/2023Ownership: 0.013%Hennion & Walsh Asset Management Inc.Bought 347,559 shares on 1/12/2023Ownership: 0.074%View All Insider TransactionsView All Institutional Transactions OPK Stock - Frequently Asked Questions Should I buy or sell OPKO Health stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OPK shares. View OPK analyst ratings or view top-rated stocks. What is OPKO Health's stock price forecast for 2023? 2 Wall Street analysts have issued twelve-month target prices for OPKO Health's stock. Their OPK share price forecasts range from $3.00 to $4.00. On average, they expect the company's share price to reach $3.50 in the next year. This suggests a possible upside of 182.3% from the stock's current price. View analysts price targets for OPK or view top-rated stocks among Wall Street analysts. How have OPK shares performed in 2023? OPKO Health's stock was trading at $1.25 on January 1st, 2023. Since then, OPK shares have decreased by 0.8% and is now trading at $1.24. View the best growth stocks for 2023 here. When is OPKO Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023. View our OPK earnings forecast. How were OPKO Health's earnings last quarter? OPKO Health, Inc. (NASDAQ:OPK) posted its earnings results on Tuesday, November, 8th. The biotechnology company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.01. The biotechnology company had revenue of $179.70 million for the quarter, compared to analyst estimates of $172.68 million. OPKO Health had a negative net margin of 25.98% and a negative trailing twelve-month return on equity of 14.79%. What is Philip Frost's approval rating as OPKO Health's CEO? 21 employees have rated OPKO Health Chief Executive Officer Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among the company's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of OPKO Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T). What is OPKO Health's stock symbol? OPKO Health trades on the NASDAQ under the ticker symbol "OPK." Who are OPKO Health's major shareholders? OPKO Health's stock is owned by many different retail and institutional investors. Top institutional investors include Hennion & Walsh Asset Management Inc. (0.07%), Sequoia Financial Advisors LLC (0.01%), Norris Perne & French LLP MI (0.01%), Transcend Capital Advisors LLC (0.01%), Shufro Rose & Co. LLC (0.00%) and RK Asset Management LLC (0.00%). Insiders that own company stock include Anthony J Japour, Elias A Zerhouni, Gary J Nabel, Jon R Cohen, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin. View institutional ownership trends. How do I buy shares of OPKO Health? Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OPKO Health's stock price today? One share of OPK stock can currently be purchased for approximately $1.24. How much money does OPKO Health make? OPKO Health (NASDAQ:OPK) has a market capitalization of $958.13 million and generates $1.22 billion in revenue each year. The biotechnology company earns $-30,140,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis. How many employees does OPKO Health have? The company employs 5,767 workers across the globe. How can I contact OPKO Health? OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The official website for the company is www.opko.com. The biotechnology company can be reached via phone at (305) 575-4100, via email at mmiller@lhai.com, or via fax at 305-575-6015. This page (NASDAQ:OPK) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.